A Day Up For Cyclacel Pharmaceuticals, Inc.
Fri, May 31, 2024 at 07:20 PM
Cyclacel Pharmaceuticals, Inc. (CYCC:NASDAQ) rocketted at $2.64, representing a gain of 30.7%. On Fri, May 31, 2024, CYCC:NASDAQ hit a New 2-Week High of $2.64. The stock got featured on our News Catalysts scanner on Tue, May 14, 2024 at 07:18 PM in the 'INVESTOR UPDATE' category. From Fri, May 17, 2024, the stock recorded 33.33% Up Days and 40.00% Green Days
The stock spiked on Wed, May 01, 2024 at $4 with a volume of 17M+.
About Cyclacel Pharmaceuticals, Inc. (CYCC:NASDAQ)
Cyclacel Pharmaceuticals Inc is a biopharmaceutical company engaged in the discovery, development and commercialization of novel, mechanism-targeted drugs to treat cancer and other serious disorders, with development operations in US and UK.
Top 10 Gainers:
- Ault Disruptive Technologies Corporation (ADRT:NYSEMKT), 233.33%
- Brand Engagement Network Inc Com (BNAI:NASDAQ), 110.85%
- Portage Biotech Inc. (PRTG:NASDAQ), 91.56%
- SRAX, Inc. (SRAX:NASDAQ), 80%
- FOXO Technologies Inc. Class A (FOXO:NYSEMKT), 39.51%
- XChange TEC.INC American Depositary Shares (XHG:NASDAQ), 31.5%
- Selina Hospitality PLC (SLNA:NASDAQ), 31.15%
- Cyclacel Pharmaceuticals, Inc. (CYCC:NASDAQ), 30.69%
- Vaccinex, Inc. (VCNX:NASDAQ), 30.13%
- Genprex, Inc. (GNPX:NASDAQ), 29.05%